TITLE

Dynamic Changes in Occupancy of Histone Variant H2A.Z during Induced Somatic Cell Reprogramming

AUTHOR(S)
Dong, Fulu; Song, Zhenwei; Yu, Jiali; Zhang, Baole; Jiang, BaoChun; Shen, Ying; Lu, Youde; Song, Chunlei; Cong, Peiqing; Liu, Honglin
PUB. DATE
December 2015
SOURCE
Sequencing;12/13/2015, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The development of induced pluripotent stem cells (iPSCs) has enabled study of the mechanisms underlying cellular reprogramming. Here, we have studied the dynamic distribution of H2A.Z during induced reprogramming with chromatin immunoprecipitation deep sequencing (ChIP-Seq). We found that H2A.Z tended to accumulate around transcription start site (TSS) and incorporate in genes with a high transcriptional activity. GO analysis with H2A.Z incorporated genes indicated that most genes are involved in chromatin assembly or disassembly and chromatin modification both in MEF and Day 7 samples, not in iPSCs. Furthermore, we detected the highest level of incorporation of H2A.Z around TSS in Day 7 samples compared to MEFs and iPSCs. GO analysis with only incorporated genes in Day 7 also displayed the function of chromatin remodeling. So, we speculate H2A.Z may be responsible for chromatin remodeling to enhance the access of transcription factors to genes important for pluripotency. This study therefore provides a deeper understanding of the mechanisms underlying induced reprogramming.
ACCESSION #
111573842

 

Related Articles

  • Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system. Drozd, Anna M.; Walczak, Maciej P.; Piaskowski, Sylwester; Stoczynska-Fidelus, Ewelina; Rieske, Piotr; Grzela, Dawid P. // Stem Cell Research & Therapy;Jul2015, Vol. 6 Issue 1, p1 

    Introduction: The prospect of therapeutic applications of the induced pluripotent stem cells (iPSCs) is based on their ability to generate virtually any cell type present in human body. Generation of iPSCs from somatic cells has opened up new possibilities to investigate stem cell biology, to...

  • Kdm2b promotes induced pluripotent stem cell generation by facilitating gene activation early in reprogramming. Liang, Gaoyang; He, Jin; Zhang, Yi // Nature Cell Biology;May2012, Vol. 14 Issue 5, p457 

    Transcription-factor-directed reprogramming from somatic cells to induced pluripotent stem cells (iPSCs) is by nature an epigenetic process of cell fate change. Previous studies have demonstrated that this inefficient process can be facilitated by the inclusion of additional factors. To gain...

  • iPSCs in Drug Discovery. Peluso, Carolyn // Drug Discovery & Development;Jul/Aug2012, Vol. 15 Issue 7, p10 

    The article discusses the significant role played by induced pluripotent stem cells (iPSCs) derived from adult somatic cells in drug discovery.

  • Stem cells: Sweetening pluripotency. Donner, Amy // Nature Chemical Biology;Jul2012, Vol. 8 Issue 7, p602 

    The article offers information on the transformation of somatic cells into induced pluripotent stem cells by the combination of transcription factors which includes octamer binding transcription factor 4 (OCT-4) and SOX2.

  • Stem cells: Efficient reprogramming from a privileged cell state.  // Nature Methods;Apr2014, Vol. 11 Issue 4, p369 

    The article discusses a research conducted by S. Guo, related to the identification of mouse granulocyte-monocyte progenitors and embryonic fibroblasts for reprogramming of somatic cells to induced pluripotency, published in a 2014 issue of the periodical "Cell."

  • Discovery Pipeline. Ritter, Amy // BioPharm International;Dec2012, Vol. 25 Issue 12, p7 

    The article offers information on the study that was published in the November 21, 2012 issue of "Cell" journal, regarding the mechanisms in the reprogramming of somatic cells into induced pluripotent stem cells (IPSCs) which are used for disease modeling.

  • Generation of iPSCs by Nonintegrative RNA-Based Reprogramming Techniques: Benefits of Self-Replicating RNA versus Synthetic mRNA. Steinle, Heidrun; Weber, Marbod; Behring, Andreas; Mau-Holzmann, Ulrike; Schlensak, Christian; Wendel, Hans Peter; Avci-Adali, Meltem // Stem Cells International;6/19/2019, p1 

    The reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) is gaining in importance in the fields of regenerative medicine, tissue engineering, and disease modeling. Patient-specific iPSCs have as an unlimited cell source a tremendous potential for generating various types of...

  • Genetic correction of β-thalassemia patient-specific iPS cells and its use in improving hemoglobin production in irradiated SCID mice. Wang, Yixuan; Zheng, Chen-Guang; Jiang, Yonghua; Zhang, Jiqin; Chen, Jiayu; Yao, Chao; Zhao, Qingguo; Liu, Sheng; Chen, Ke; Du, Juan; Yang, Ze; Gao, Shaorong // Cell Research;Apr2012, Vol. 22 Issue 4, p637 

    The generation of induced pluripotent stem cells (iPSCs) from differentiated somatic cells by over-expression of several transcription factors has the potential to cure many genetic and degenerative diseases currently recalcitrant to traditional clinical approaches. One such genetic disease is...

  • Induced pluripotent stem cells: the new patient? Bellin, Milena; Marchetto, Maria C.; Gage, Fred H.; Mummery, Christine L. // Nature Reviews Molecular Cell Biology;Nov2012, Vol. 13 Issue 11, p713 

    Worldwide increases in life expectancy have been paralleled by a greater prevalence of chronic and age-associated disorders, particularly of the cardiovascular, neural and metabolic systems. This has not been met by commensurate development of new drugs and therapies, which is in part owing to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics